China Universal Asset Management Co., Ltd. Bridge Bio Pharma, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 38,149 shares of BBIO stock, worth $1.74 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
38,149
Previous 40,073
4.8%
Holding current value
$1.74 Million
Previous $1.1 Million
19.93%
% of portfolio
0.13%
Previous 0.11%
Shares
16 transactions
Others Institutions Holding BBIO
# of Institutions
372Shares Held
184MCall Options Held
12.8MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$1.01 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$879 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$680 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$568 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$327 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.76B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...